<?xml version="1.0"?>

<document>
	<title>Differential concanavalin A binding of cystic fibrosis and normal
   liver alpha-L-fucosidase.</title>

	<author>Alhadeff-J-A.</author>
	<author>Watkins-P.</author>

	<source>Biochem-Biophys-Res-Commun. 1979 Feb 14. 86(3). P 787-92.</source>

	<abstract>A novel technique has been employed to demonstrate that alpha-L-
   fucosidase purified from cystic fibrosis and control livers exhibits
   differential binding to the lectin Concanavalin A.  The
   concentration of alpha-CH3-mannoside necessary to prevent 50%
   binding of alpha-L-fucosidase to Concanavalin A is considerably
   lower for the cystic fibrosis enzyme (13.5 vs. 33.3 mM).  Comparable
   results were found when binding studies were done on crude
   supernatant alpha-L-fucosidase from 8 cystic fibrosis and 8 control
   livers (5.6 plus or minus 0.4 mM and 13.2 plus or minus 3.4
   respectively), without any overlap of values between the cystic
   fibrosis and control livers.  These results suggest that comparative
   lectin binding studies on cystic fibrosis and normal glycoproteins
   from readily available tissues might result in an assay for
   detecting the cystic fibrosis genotype.</abstract>

	<majorsubject>CONCANAVALIN-A: me</majorsubject>
	<majorsubject>CYSTIC-FIBROSIS: en</majorsubject>
	<majorsubject>FUCOSIDASE: me</majorsubject>
	<majorsubject>LIVER: en</majorsubject>

	<minorsubject>COMPARATIVE-STUDY</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>KINETICS</minorsubject>
	<minorsubject>PROTEIN-BINDING</minorsubject>
	<minorsubject>SUPPORT-U-S-GOVT-P-H-S</minorsubject>

	<reference>001   MCCOMBS ML            TEX REP BIOL MED                31   615 973</reference>
	<reference>002   NADLER HL             IN: STANBURY JB                     1683 978</reference>
	<reference>003   WRIGHT SW             AM J HUM GENET                  20   157 968</reference>
	<reference>005   ALHADEFF JA           CLIN GENET                      13   417 978</reference>
	<reference>006   ALHADEFF JA           J BIOL CHEM                    250  7106 975</reference>
	<reference>007   ALHADEFF JA           MOL CELL BIOCHEM                18    33 977</reference>
	<reference>008   ALHADEFF JA           CLIN GENET                      10    63 976</reference>
	<reference>009   ALHADEFF JA           IN: GLEW RH                          247 977</reference>
	<reference>010   BISHAYEE S            BIOCHIM BIOPHYS ACTA           334   378 974</reference>
	<reference>011   HOSLI P               BIOCHEM BIOPHYS RES COMMUN      79   741 977</reference>
	<reference>012   SCANLIN TF JR         BIOCHEM BIOPHYS RES COMMUN      79   869 977</reference>
	<reference>013   SCANLIN TF JR         PEDIATR RES ABST 549            11   463 977</reference>
	<reference>014   LIS H                 IN: SELA M                       4   429 977</reference>

	<citation>1   SHAPIRA E             BIOCHEM BIOPHYS RES COMMUN      93    50 980</citation>
	<citation>2   ALHADEFF JA           CLIN CHIM ACTA                 105   131 980</citation>
	<citation>3   HALLINAN F            MED HYPOTHESES                   7   793 981</citation>
	<citation>4   ALHADEFF JA           CLIN CHIM ACTA                 117   227 981</citation>
	<citation>5   MALER T               J BIOL CHEM                    256  1420 981</citation>
	<citation>6   SCANLIN TF            BIOCHEMISTRY                    21   491 982</citation>
	<citation>7   BOURASSA C            CLIN CHIM ACTA                 129   263 983</citation>
	<citation>8   HERMELIN B            CELL MOL BIOL                   33    83 987</citation>

</document>
